Fortis Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,852	Closed	-$1.12M	–	283
2024 Q4	$1.12M	Buy	+8,852	New	+$1.12M	0.38%	54
2024 Q3	–	Sell	-8,113	Closed	-$1.12M	–	194
2024 Q2	$1.12M	Buy	8,113 +3,877	+92%	+$534K	0.4%	46
2024 Q1	$584K	Buy	+4,236	New	+$584K	0.25%	72